Company: FCRS
Filing Date: 2025-08-05
Form Type: DRS
Source: 0001213900-25-071556
Chunk: 5

Company: FutureCrest Acquisition Corp.
Filing Date: 2025-08-05
Form: DRS
Chunk 5
---
 of our shareholders prior to or in connection with the completion of our initial business combination, holders of the Class B ordinary shares and holders of the Class A ordinary shares will vote together as a single class, except as required by law. Collectively, the Class B ordinary shares and the shares underlying the private placement warrants will represent 31.64% of all ordinary shares outstanding, assuming the conversion of all warrants and that the underwriters’ over -allotmentoption is not exercised. Upon consummation of this offering or thereafter, we will repay up to $300,000 in loans made to us by our sponsor to cover offering -relatedand organizational expenses, and In the event that following this offering we obtain working capital loans from our sponsor to finance transaction costs related to our initial business combination, up to $1,500,000 of such loans may be convertible into warrants of the post -businesscombination entity at a price of $2.00 per warrant at the option of our sponsor. Additionally, our sponsor, officers, directors or advisors may be paid a finder’s fee, advisory fee, consulting fee or success fee in order to effectuate the completion of our initial business combination. Additionally, following consummation of a business combination, members of our management team will be entitled to reimbursement for any out -of -pocketexpenses related to identifying, investigating and completing an initial business combination. Each of our directors will also receive for his or her service as a director an indirect interest in 25,000 founder shares through membership interests in our sponsor. As a result, there may be actual or potential material conflicts of interest between members of our management team, our sponsor and its affiliates on one hand, and purchasers in this offering on the other. See “Summary — Sponsor Information” on page 9, “Summary — The Offering — Founder Shares” on page 17, “Summary — The Offering — Transfer Restrictions on Founder Shares” on page 19, and “Summary — The Offering — Founder Shares Conversion and Anti -Dilution Rights” on page 19 and “Risk Factors — Risks Relating to our Securities — The nominal purchase price paid by our sponsor for the founder shares may result in significant dilution to the implied value of your public shares upon the consummation of our initial business combination, and our sponsor is likely to make a substantial profit on its investment in us in the event we consummate an initial business combination, even if the business combination causes the trading price of our ordinary shares to materially decline.” on page